CD274 and neoplasm: Additionally, it counteracts tumor immune evasion by influencing the methylation of N6-methyladenosine and the translation of immune checkpoint molecules, such as PD-L1 and the V-domain Ig suppressor of T-cell activation, thereby inhibiting their expression in tumor cells [121].